MTOR and in situ carcinoma: Similarly, a significant elevation in p-mTOR concentrations was observed in the kidneys of the CIS-treated Gal-3 KO mice compared to Gal-3 KO sham control mice, demonstrating statistical significance (p < 0.001) (Figure 7B).